UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Supramolecular Stacking of Doxorubicin on Carbon Nanotubes for In Vivo Cancer Therapy

Angewandte Chemie (International ed.), 2009-01, Vol.48 (41), p.7668-7672

2009

Volltextzugriff (PDF)

A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients

The American journal of surgical pathology, 2020-01, Vol.44 (1), p.98-110

2020

Volltextzugriff (PDF)

Alteration of the lipid profile in lymphomas induced by MYC overexpression

Proceedings of the National Academy of Sciences - PNAS, 2014-07, Vol.111 (29), p.10450-10455

2014

Volltextzugriff (PDF)

Diverse and abundant phages exploit conjugative plasmids

Nature communications, 2024-04, Vol.15 (1), p.3197-3197, Article 3197

2024

Volltextzugriff (PDF)

Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation

Proceedings of the National Academy of Sciences - PNAS, 2007-08, Vol.104 (32), p.13028-13033

2007

Volltextzugriff (PDF)

The ‘Achilles Heel’ of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy

Kidney Cancer, 2019-02, Vol.3 (1), p.15-29

2019

Volltextzugriff (PDF)

Return of individual research results: What do participants prefer and expect?

PloS one, 2021-07, Vol.16 (7), p.e0254153

2021

Volltextzugriff (PDF)

Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma

Cancers, 2019-07, Vol.11 (7), p.1000

2019

Volltextzugriff (PDF)

Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas

PloS one, 2008-05, Vol.3 (5), p.e2125

2008

Volltextzugriff (PDF)

Early Changes in CT Perfusion Parameters: Primary Renal Carcinoma Versus Metastases After Treatment with Targeted Therapy

Cancers, 2019-04, Vol.11 (5), p.608

2019

Volltextzugriff (PDF)

Sustained Regression of Tumors upon MYC Inactivation Requires P53 or Thrombospondin-1 to Reverse the Angiogenic Switch

Proceedings of the National Academy of Sciences - PNAS, 2006-10, Vol.103 (44), p.16266-16271

2006

Volltextzugriff (PDF)

BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia

Oncotarget, 2016-05, Vol.7 (19), p.26926-26934

2016

Volltextzugriff (PDF)

Identification of Rocaglate Acyl Sulfamides as Selective Inhibitors of Glioblastoma Stem Cells

ACS central science, 2024-08, Vol.10 (8), p.1640-1656

2024

Volltextzugriff (PDF)

High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells

Science translational medicine, 2017-02, Vol.9 (377)

2017

Volltextzugriff (PDF)

Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancer

Journal of patient-reported outcomes, 2021-09, Vol.5 (1), p.91-91, Article 91

2021

Volltextzugriff (PDF)

CD4 + T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation

Cancer cell, 2010-11, Vol.18 (5), p.485-498

2010

Volltextzugriff (PDF)

Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial

Clinical cancer research, 2022-08, Vol.28 (15), p.3248-3255

2022

Volltextzugriff (PDF)

Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds

Proceedings of the National Academy of Sciences - PNAS, 2009-03, Vol.106 (11), p.4390-4395

2009

Volltextzugriff (PDF)

Recurrent repeat expansions in human cancer genomes

Nature (London), 2023-01, Vol.613 (7942), p.96-102

2023

Volltextzugriff (PDF)

Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

Clinical cancer research, 2022-04, Vol.28 (8), p.1540-1548

2022

Volltextzugriff (PDF)

Oncogene withdrawal engages the immune system to induce sustained cancer regression

Journal for Immunotherapy of Cancer, 2014-07, Vol.2 (1), p.24-24

2014

Volltextzugriff (PDF)

Lay healthcare worker financial toxicity intervention: a pilot financial toxicity screening and referral program

Supportive care in cancer, 2024-03, Vol.32 (3), p.161-161, Article 161

2024

Volltextzugriff (PDF)

1 – 25 von 513

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(502)
Mit Volltextzugriff
(464)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(274)
Physics
(187)
Physical Sciences
(171)
Fysik
(151)
Natural Sciences
(151)
Naturvetenskap
(151)
Subatomic Physics
(150)
Subatomär Fysik
(150)
Life Sciences & Biomedicine
(134)
Nuclear Physics
(103)
Humans
(99)
Physics, Particles & Fields
(97)
High Energy Physics - Experiment
(93)
Nuclear Experiment
(91)
Physics Of Elementary Particles And Fields
(85)
Experiment
(80)
Particle Physics
(77)
Physics And Astronomy
(73)
Elementary Particles
(72)
Quantum Field Theories
(71)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Supramolecular Stacking of Doxorubicin on Carbon Nanotubes for In Vivo Cancer Therapy

A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients

Alteration of the lipid profile in lymphomas induced by MYC overexpression

Diverse and abundant phages exploit conjugative plasmids

Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation

The ‘Achilles Heel’ of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy

Return of individual research results: What do participants prefer and expect?

KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study

Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma

Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas

Early Changes in CT Perfusion Parameters: Primary Renal Carcinoma Versus Metastases After Treatment with Targeted Therapy

Sustained Regression of Tumors upon MYC Inactivation Requires P53 or Thrombospondin-1 to Reverse the Angiogenic Switch

BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia

Identification of Rocaglate Acyl Sulfamides as Selective Inhibitors of Glioblastoma Stem Cells

High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells

Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancer

CD4 + T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation

Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial

Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds

Recurrent repeat expansions in human cancer genomes

Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

Oncogene withdrawal engages the immune system to induce sustained cancer regression

Corrigendum to “KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study” [Leuk. Res. 50 (Nov) (2016) 123–131. PubMed PMID: 27736729]

Lay healthcare worker financial toxicity intervention: a pilot financial toxicity screening and referral program

Suchergebnisse filtern